Sandeep Nathan
Cardiovascular Disease · Chicago, ILNPI 1225054588
Payments from drug & device makers
Across 846 payments — averaging $1291.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- ZOLL Circulation Inc$327K
- Johnson & Johnson$280K
- Medtronic$175K
- Merit Medical Systems Inc$81K
- Shockwave Medical, Inc$48K
- Abbott$33K
- plus $149K from 32 others
Across 1 payment — averaging $220.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- ZOLL Circulation Inc$220
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| ZOLL Circulation Inc | 95 | $326,557 |
| Johnson & Johnson | 139 | $279,545 |
| Medtronic(2 entities) | 120 | $175,144 |
| Merit Medical Systems Inc | 54 | $81,313 |
| Shockwave Medical, Inc | 38 | $48,059 |
| Abbott | 27 | $33,044 |
| Biotronik Inc. | 64 | $30,593 |
| Terumo Medical Corporation | 32 | $19,186 |
| Chiesi USA, Inc. | 6 | $18,361 |
| Abiomed | 60 | $15,398 |
| Magenta Medical Inc | 8 | $14,284 |
| AstraZeneca | 11 | $12,746 |
| Getinge USA Sales, LLC | 7 | $10,250 |
| Cardiovascular Systems Inc. | 20 | $9,778 |
| Penumbra, Inc. | 9 | $6,318 |
| Boston Scientific | 26 | $4,042 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 21 | $2,135 |
| Edwards Lifesciences | 15 | $1,478 |
| Teleflex LLC | 11 | $882 |
| Inari Medical, Inc. | 25 | $629 |
| Philips North America LLC | 9 | $597 |
| Janssen Scientific Affairs, LLC | 6 | $416 |
| Cvrx, Inc. | 3 | $404 |
| Procyrion, Inc. | 4 | $294 |
| Acist Medical Systems, Inc. | 7 | $238 |
| Cardiva Medical, Inc. | 7 | $192 |
| Livanova USA, Inc. | 2 | $183 |
| Cathworks, Inc. | 2 | $181 |
| Bard Peripheral Vascular, Inc. | 1 | $150 |
| Amgen | 4 | $102 |
| Angiodynamics, Inc. | 2 | $61 |
| Stryker | 2 | $44 |
| Elutia, Inc. | 3 | $44 |
| E.r. Squibb & Sons, L.L.C. | 2 | $40 |
| Cordis US CORP. | 1 | $32 |
| Esperion Therapeutics, Inc. | 1 | $24 |
| Novartis | 1 | $20 |
| Opsens Inc. | 1 | $17 |
How this compares
$1,092,779 in reported general payments places this provider in the 95th percentile of 932 cardiovascular disease providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other cardiovascular disease in Chicago
- Benjamin LumicaoChicago$3.7M
- Paul CremerChicago$2.9M
- Nitasha SarswatChicago$2M
- Sanjiv ShahChicago$1.2M
- Boaz AvitallChicago$663K
- Ravi PatelChicago$488K
- Lubna ChoudhuryChicago$476K
- Akhil NarangChicago$427K
- Amit AminChicago$407K
- Michael DavidsonChicago$317K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.